Quaak M, van Schayck CP, Knaapen AM, van Schooten FJ. Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases? Eur Respir J. 2009;33:468–80.
Kim YS, Ko H, Yoon C, Lee DH, Sung J. Social determinants of smoking behavior: the healthy twin study, Korea. J Prev Med Public Health. 2012;45:29–36.
Wright AJ, French DP, Weinman J, Marteau TM. Can genetic risk information enhance motivation for smoking cessation? An analogue study. Health Psychol. 2006;25:740–52.
Tsuang MT, Francis T, Minor K, Thomas A, Stone WS. Genetics of smoking and depression. Hum Genet. 2012;131:905–15.
Di YM, Chow VD, Yang LP, Zhou SF. Structure, function, regulation and polymorphism of human cytochrome P450 2A6. Curr Drug Metab. 2009;10:754–80.
Benowitz NL, Hukkanen J, Jacob P. 3rd. Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol. 2009;192:29–60.
Mwenifumbo JC, Myers MG, Wall TL, Lin SK, Sellers EM, Tyndale RF. Ethnic variation in CYP2A6*7, CYP2A6*8 and CYP2A6*10 as assessed with a novel haplotyping method. Pharmacogenetics Genom. 2005;15:189–92.
Jimenez-Jimenez FJ, Alonso-Navarro H, Garcia-Martin E, Agundez JA. COMT gene and risk for Parkinson’s disease: a systematic review and meta-analysis. Pharmacogenetics Genom. 2014;24:331–9.
Beuten J, Payne TJ, Ma JZ, Li MD. Significant association of catechol-O-methyltransferase (COMT) haplotypes with nicotine dependence in male and female smokers of two ethnic populations. Neuropsychopharmacology. 2006;31:675–84.
Berrettini WH, Wileyto EP, Epstein L, Restine S, Hawk L, Shields P, Niaura R, Lerman C. Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence. Biol Psychiatry. 2007;61:111–8.
Suriyaprom K, Tungtrongchitr R, Harnroongroj T. Impact of COMT Val 108/158 Met and DRD2 Taq1B gene polymorphisms on vulnerability to cigarette smoking of Thai males. J Mol Neurosci. 2013;49:544–9.
Health Promotion Administration. Taiwan tobacco control: annual report 2012. 2013. http://health99.hpa.gov.tw/media/public/zip/21747.zip. Accessed 24 Apr 2016.
Chen YT, Tsou HH, Kuo HW, Fang CP, Wang SC, Ho IK, Chang YS, Chen CH, Hsiao CF, Wu HY, et al. OPRM1 genetic polymorphisms are associated with the plasma nicotine metabolite cotinine concentration in methadone maintenance patients: a cross sectional study. J Hum Genet. 2013;58:84–90.
Huang CL, Ou WC, Chen PL, Liu CN, Chen MC, Lu CC, Chen YC, Lin MH, Huang CS. Effects of interaction between dopamine D2 receptor and monoamine oxidase a genes on smoking status in young men. Biol Res Nurs. 2015;17:422–8.
Tochigi M, Suzuki K, Kato C, Otowa T, Hibino H, Umekage T, Kato N, Sasaki T. Association study of monoamine oxidase and catechol-O-methyltransferase genes with smoking behavior. Pharmacogenetics Genom. 2007;17:867–72.
Shiels MS, Huang HY, Hoffman SC, Shugart YY, Bolton JH, Platz EA, Helzlsouer KJ, Alberg AJ. A community-based study of cigarette smoking behavior in relation to variation in three genes involved in dopamine metabolism: Catechol-O-methyltransferase (COMT), dopamine beta-hydroxylase (DBH) and monoamine oxidase-A (MAO-A). Prev Med. 2008;47:116–22.
Tang X, Guo S, Sun H, Song X, Jiang Z, Sheng L, Zhou D, Hu Y, Chen D. Gene-gene interactions of CYP2A6 and MAOA polymorphisms on smoking behavior in Chinese male population. Pharmacogenetics Genom. 2009;19:345–52.
Rodriguez S, Cook DG, Gaunt TR, Nightingale CM, Whincup PH, Day IN. Combined analysis of CHRNA5, CHRNA3 and CYP2A6 in relation to adolescent smoking behaviour. J Psychopharmacol. 2011;25:915–23.
Wassenaar CA, Dong Q, Wei Q, Amos CI, Spitz MR, Tyndale RF. Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk. J Natl Cancer Inst. 2011;103:1342–6.
Ohmoto M, Takahashi T, Kubota Y, Kobayashi S, Mitsumoto Y. Genetic influence of dopamine receptor, dopamine transporter, and nicotine metabolism on smoking cessation and nicotine dependence in a Japanese population. BMC Genet. 2014;15:151.
Doran N. Sex differences in smoking cue reactivity: craving, negative affect, and preference for immediate smoking. Am J Addict. 2014;23:211–7.
Huang CL, Cheng CP, Huang HW. The development of a Chinese-language instrument to measure social smoking motives among male Taiwanese smokers. J Transcult Nurs. 2013;24:371–7.
Mwenifumbo JC, Lessov-Schlaggar CN, Zhou Q, Krasnow RE, Swan GE, Benowitz NL, Tyndale RF. Identification of novel CYP2A6*1B variants: the CYP2A6*1B allele is associated with faster in vivo nicotine metabolism. Clin Pharmacol Ther. 2008;83:115–21.
Schoedel KA, Hoffmann EB, Rao Y, Sellers EM, Tyndale RF. Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians. Pharmacogenetics. 2004;14:615–26.
Huang CL, Lin HH, Wang HH. The psychometric properties of the Chinese version of the fagerstrom test for nicotine dependence. Addict Behav. 2006;31:2324–7.
Lu CC, Lin HH, Chen CJ, Huang CL. Psychometric testing of the Chinese version of the dimensions of Tobacco Dependence Scale. J Clin Nurs. 2009;18:2470–7.
Huang CL, Lin HH, Wang HH. Cigarette dependence questionnaire: development and psychometric testing with male smokers. J Adv Nurs. 2010;66:2341–9.
Raunio H, Rahnasto-Rilla M. CYP2A6: genetics, structure, regulation, and function. Drug Metabol Drug Interact. 2012;27:73–88.
Nurfadhlina M, Foong K, Teh LK, Tan SC, Mohd Zaki S, Ismail R. CYP2A6 polymorphisms in Malays, Chinese and Indians. Xenobiotica. 2006;36:684–92.
Oscarson M, McLellan RA, Gullsten H, Yue QY, Lang MA, Bernal ML, Sinues B, Hirvonen A, Raunio H, Pelkonen O, Ingelman-Sundberg M. Characterisation and PCR-based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population. FEBS Lett. 1999;448:105–10.
Chiang CT. The polymorphisms of CYP2A6 among Taiwanese lung cancer patients. Master’s thesis. Chunghua University (Tainan, Taiwan). 2006. http://handle.ncl.edu.tw/11296/ndltd/29131916603407156420. Accessed 24 Apr 2016.
Chan RC, Chen RY, Chen EY, Hui TC, Cheung EF, Cheung HK, Sham P, Li T, Collier D. The differential clinical and neurocognitive profiles of COMT SNP rs165599 genotypes in schizophrenia. J Int Neuropsychol Soc. 2005;11:202–4.
Dempsey D, Tutka P, Jacob P 3rd, Allen F, Schoedel K, Tyndale RF, Benowitz NL. Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity. Clin Pharmacol Ther. 2004;76:64–72.
Iwahashi K, Waga C, Takimoto T. Whole deletion of CYP2A6 gene (CYP2A6AST;4C) and smoking behavior. Neuropsychobiology. 2004;49:101–4.
Waga C, Iwahashi K. CYP2A6 gene polymorphism and personality traits for NEO-FFI on the smoking behavior of youths. Drug Chem Toxicol. 2007;30:343–9.
Liu T, David SP, Tyndale RF, Wang H, Zhou Q, Ding P, He YH, Yu XQ, Chen W, Crump C, et al. Associations of CYP2A6 genotype with smoking behaviors in southern China. Addiction. 2011;106:985–94.
O’Loughlin J, Paradis G, Kim W, DiFranza J, Meshefedjian G, McMillan-Davey E, Wong S, Hanley J, Tyndale RF. Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokers. Tob Control. 2004;13:422–8.
Gold AB, Lerman C. Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes. Hum genet. 2012;131(6):857–76.
Chenoweth MJ, O’Loughlin J, Sylvestre MP, Tyndale RF. CYP2A6 slow nicotine metabolism is associated with increased quitting by adolescent smokers. Pharmacogenetics Genom. 2013;23:232–5.
Nedic G, Nikolac M, Borovecki F, Hajnsek S, Muck-Seler D, Pivac N. Association study of a functional catechol-O-methyltransferase polymorphism and smoking in healthy Caucasian subjects. Neurosci Lett. 2010;473:216–9.
Redden DT, Shields PG, Epstein L, Wileyto EP, Zakharkin SO, Allison DB, Lerman C. Catechol-O-methyl-transferase functional polymorphism and nicotine dependence: an evaluation of non replicated results. Cancer Epidemiol Biomark Prev. 2005;14:1384–9.
Guo S, da Chen F, Zhou DF, Sun HQ, Wu GY, Haile CN, Kosten TA, Kosten TR, Zhang XY. Association of functional catechol O-methyl transferase (COMT) Val108Met polymorphism with smoking severity and age of smoking initiation in Chinese male smokers. Psychopharmacology. 2007;190:449–56.
Munafo MR, Freathy RM, Ring SM, St Pourcain B, Smith GD. Association of COMT Val(108/158)Met genotype and cigarette smoking in pregnant women. Nicotine Tob Res. 2011;13:55–63.
Nagano T, Shimizu M, Kiyotani K, Kamataki T, Takano R, Murayama N, Shono F, Yamazaki H. Biomonitoring of urinary cotinine concentrations associated with plasma levels of nicotine metabolites after daily cigarette smoking in a male Japanese population. Int J Environ Res Public Health. 2010;7:2953–64.
Wang KY, Yang CC, Chu NF, Wu DM. Predictors of cigarette smoking behavior among military university students in Taiwan. J Nurs Res. 2009;17:161–9.
Eticha T, Kidane F. The prevalence of and factors associated with current smoking among College of Health Sciences students, Mekelle University in northern Ethiopia. PLoS ONE. 2014;9:e111033.
Wilkinson AV, Swartz MD, Yu X, Spitz MR, Shete S. Cigarette experimentation and the population attributable fraction for associated genetic and non-genetic risk factors. PLoS ONE. 2013;8:e53868.